Stroke treatment firm reels in €3m
This article was originally published in Clinica
Electrical Brain Synchronisation (EBS) Technologies, a German start-up specialising in treatment of neurological deficits in stroke and brain trauma patients, has raised €3m ($4.3m) in its second financing round. Earlybird Venture Capital was the lead investor; BC Brandenburg Capital and High-Tech Gründerfonds also participated in the financing. EBS is developing a therapy that provides noninvasive electrical stimulation to the brain, using head-mounted electrodes. The therapy aims to help the brain "re-learn" its natural synchronisation, particularly for vision and speech functions, and facilitate better and faster rehabilitation. The €3m raised will enable the Kleinmachnow-based firm to take its medical device to market and carry out further clinical for additional indications.
You may also be interested in...
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.
Philips has added a new pulse oximetry platform to its patient monitoring portfolio, with the acquisition of Xhale Assurance.